Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Peringkat dalam Saham #40869
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Harga Saham
$0.02765
Terakhir disinkronkan: 2024-12-23
Kapitalisasi Pasar
$69.04K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Histogen Inc. (HSTO)

Kategori

Riwayat pemecahan saham untuk Histogen Inc. (HSTO)
Saham Histogen Inc. (simbol: HSTO) telah mengalami total 2 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Jun 03, 2022.
Satu lembar saham HSTO yang dibeli sebelum May 27, 2020 sekarang setara dengan 0.005 lembar saham HSTO.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
2022-06-03 1:20 x0.05 x0.005
2020-05-27 1:10 x0.1 x0.1
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE